GENENTA SCIENCE(SP.ADR)/1 (K5F) — Defensive Interval Ratio

Latest as of December 2025: 3899 days

GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Defensive Interval Ratio of 3899 days as of December 2025. Defensive assets of €22.62 Million (cash €-, short-term investments €22.62 Million, receivables €-) cover 3899 days of daily cash needs of €5.80K/day. Check GENENTA SCIENCE(SP.ADR)/1 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

3899 days
Days of operational coverage

Defensive Assets

€22.62 Million
Cash + ST Investments + Receivables

Daily Cash Need

€5.80K
Current Liabilities ÷ 365

Current Liabilities

€2.12 Million
EUR

GENENTA SCIENCE(SP.ADR)/1 Defensive Interval Ratio (2021–2025)

This chart shows how GENENTA SCIENCE(SP.ADR)/1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 3899 days, meaning defensive assets of €22.62 Million can fund 3899 days of operations without new revenue. Also explore GENENTA SCIENCE(SP.ADR)/1 (K5F) equity growth momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for GENENTA SCIENCE(SP.ADR)/1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see GENENTA SCIENCE(SP.ADR)/1 market cap and net worth.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 3899 days €22.62 Million €5.80K/day €- €22.62 Million ▲ +2494 days
2024 1404 days €8.08 Million €5.75K/day €- €8.08 Million ▼ -1768 days
2023 3172 days €15.08 Million €4.76K/day €- €15.08 Million ▲ +3172 days
2022 0 days €0.00 €5.98K/day €- €0.00 ▲ +0 days
2021 0 days €0.00 €3.11K/day €- €0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)